Quantification of analgesic use in children with sickle cell disease

Clinical Journal of Pain

Volumn 23, Issue 1, 2007, Pages 8-14

  Jacob, Eufemia ^a,b   Miaskowski, Christine ^c   Savedra, Marilyn ^c   Beyer, Judith E ^d   Treadwell, Marsha ^e   Styles, Lori ^f  

^a TEXAS CHILDREN S CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Sickle Cell Center   (United States)

^e CHILDREN S HOSPITAL OAKLAND   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Acute painful episode; Analgesic use; Medication quantification scale; Pain management; Sickle cell disease; Sickle cell pain

Indexed keywords

ANALGESIC AGENT; KETOROLAC; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; DOSE RESPONSE; DRUG UTILIZATION; FEMALE; HUMAN; MALE; METHODOLOGY; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SICKLE CELL ANEMIA; VASCULAR DISEASE;

ADOLESCENT; ADULT; ANALGESICS; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION; FEMALE; HUMANS; KETOROLAC; MALE; MORPHINE; PAIN; PAIN MEASUREMENT; VASCULAR DISEASES;

EID: 33847299107     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/01.ajp.0000210938.58439.dd     Document Type: Article

References (38)

1. Benjamin LJ, Dampier CD, Jacox AK, et al. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. Glenview, IL: American Pain Society; 1999.
2. Robieux IC, Kellner JD, Coppes MJ, et al. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebocontrolled study of oxygen inhalation. Pediatr Hematol Oncol. 1992;9:317-326.
3. Dampier CD, Setty BN, Logan J, et al. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr. 1995;126:461-467.
4. Shapiro BS, Cohen DE. Patient-controlled analgesia for sickle cellrelated pain. J Pain Symptom Manage. 1993;8:22-28.
5. Christensen ML, Wang WC, Harris S, et al. Transdermal fentanyl administration in children and adolescents with sickle cell pain crisis. J Pediatr Hematol Oncol. 1996;18:372-376.
6. Yaster M, Tobin JR, Billett C, et al. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Pediatrics. 1994;93:310-315.
7. Beyer JE. Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease. J Pain Symptom Manage. 2000;19:63-72.
8. Dampier C, Ely B, Brodecki D, et al. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain. 2002;3:461-470.
9. Steedman SM, Middaugh SJ, Carson WGKS, et al. Chronic-pain medications: equivalence levels and method of quantifying usage. Clin J Pain. 1992;8:204-213.
10. Jacob E, Miaskowski C, Savedra M, et al. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain. 2003;102:187-193.
11. Jacob E, Miaskowski C, Savedra M, et al. Management of vasoocclusive pain in hospitalized children with sickle cell disease. J Pediatr Hematol Oncol. 2003;25:307-311.
12. Beyer J, Aradine C. Content validity of an instrument to measure young children's perceptions of the intensity of their pain. J Pediatr Nurs. 1986;1:386-395.
13. Beyer J, Aradine C. The convergent and discriminant validity of a self-report measure of pain intensity for children. Child Health Care. 1988;16:130-141.
14. Beyer J, Denyes M, Villarruel A. The creation, validation, and continuing development of the Oucher: a measure of pain intensity in children. J Pediatr Nurs. 1992;7:335-346.
15. Beyer JE, Knott CB. Construct validity estimation for the African-American and Hispanic versions of the Oucher scale. J Pediatr Nurs. 1998;13:20-31.
16. Savedra MC, Tesler MD, Holzemer WL, et al. Pain location: validity and reliability of body outline markings by hospitalized children and adolescents. Res Nurs Health. 1989;12:307-314.
17. Savedra MC, Holzemer WL, Tesler MD, et al. Assessment of postoperation pain in children and adolescents using the Adolescent Pediatric Pain Tool. Nurs Res. 1993;42:5-9.
18. Tesler M, Savedra M, Ward JA, et al. The word-graphic rating scale as a measure of children's and adolescents' pain intensity. Res Nurs Health. 1991;14:361-371.
19. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. Hudson, Ohio: Lexi-comp, Inc; 2006.
20. Kee W, Steedman S, Middaugh S. Medication Quantification Scale (MQS): update of detriment weights and medication additions. Am J Pain Manage. 1998;8:83-88.
21. Weinland S, Harden R, Houle T, et al. Medication Quantification Scale-III (MQS): Revision of Detriment Weights by Consensus of American Pain Society Prescribing Physicians. Chicago, Illinois: American Pain Society; 2003.
22. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Clarendon Press; 1994.
23. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996:633.
24. Alleyne J, Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs. 1994;19: 725-732.
25. Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. Br Med J. 1999;318:1585-1590.
26. Shapiro BS, Benjamin LJ, Payne R, et al. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-174.
27. Altimier L, Norwood S, Dick M, et al. Postoperative pain management in preverbal children: the prescription and administration of analgesics with and without caudal analgesia. J Pediatr Nurs. 1994;9:226-232.
28. Jacob E, Puntillo K. Variability of analgesic practices for hospitalized children on different pediatric units. J Pain Symptom Manage. 2000;20:59-67.
29. Romsing J. Assessment of nurses' judgment for analgesic requirement of postoperative children. J Clin Pharm Ther. 1996;21: 159-163.
30. Tesler M, Wilkie D, Holzemer W, et al. Postoperative analgesics for children and adolescents: prescription and administration. J Pain Symptom Manage. 1994;9:85-95.
31. Ballas SK. The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin. 1995;19:323-333.
32. Ballas S. The Acute Painful Episode, Sickle Cell Pain. Seattle: IASP Press; 1998:201-237.
33. Ballas SK, Kramer SA. Acute sickle cell painful episodes: evolution of the clinical picture. J Pain. 2001;2:18.
34. Beyer J, Simmons L, Woods GM, et al. A chronology of pain/comfort in children with sickle cell disease. Arch Pediatr Adolesc Med. 1999;153:913-920.
35. Drake R, Longworth J, Collins JJ. Opioid rotation in children with cancer. J Palliat Med. 2004;7:419-422.
36. Tobias JD, Baker DK. Patient-controlled analgesia with fentanyl in children. Clin Pediatr (Phila). 1992;31:177-179.
37. Jacobson SJ, Kopecky EA, Joshi P, et al. Randomised trial of morphine for painful episodes of sickle cell disease in children. Lancet. 1997;350:1359-1361.
38. Shaiova L, Wallenstein D. Outpatient management of sickle cell pain with chronic opioid pharmacotherapy. J Natl Med Assoc. 2004;96:1-3.